177 related articles for article (PubMed ID: 25815756)
21. Re-administration of mirtazapine could overcome previous mirtazapine- associated restless legs syndrome?
Pae CU; Kim TS; Kim JJ; Chae JH; Lee CU; Lee SJ; Paik IH; Lee C
Psychiatry Clin Neurosci; 2004 Dec; 58(6):669-70. PubMed ID: 15601394
[No Abstract] [Full Text] [Related]
22. Methodological approach to brain-derived neurotrophic factor plasma levels in major depressed patients receiving duloxetine.
Agilli M; Aydin FN
Neurol Sci; 2015 Jun; 36(6):1061-2. PubMed ID: 25637063
[No Abstract] [Full Text] [Related]
23. Open trials in psychiatry: comments on article by Uchida et Al.
Magalhães PV
J Clin Psychopharmacol; 2007 Jun; 27(3):318; author reply 318-9. PubMed ID: 17502793
[No Abstract] [Full Text] [Related]
24. Restless legs syndrome induced by citalopram: a psychiatric emergency?
Perroud N; Lazignac C; Baleydier B; Cicotti A; Maris S; Damsa C
Gen Hosp Psychiatry; 2007; 29(1):72-4. PubMed ID: 17189751
[TBL] [Abstract][Full Text] [Related]
25. [Brief case report. Duloxetine in Cotard syndrome].
Kozian R
Psychiatr Prax; 2005 Nov; 32(8):412-3. PubMed ID: 16342026
[No Abstract] [Full Text] [Related]
26. Paroxetine and the FDA.
Brent DA
J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):127-8. PubMed ID: 14971062
[No Abstract] [Full Text] [Related]
27. Drug-induced movement disorder and confusion associated with duloxetine.
Siddiqui SH; Memon NA; Shanker R
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29592972
[TBL] [Abstract][Full Text] [Related]
28. Comparative Efficacy of Newer Antidepressants in Combination with Pregabalin for Fibromyalgia Syndrome: A Controlled, Randomized Study.
Ramzy EA
Pain Pract; 2017 Jan; 17(1):32-40. PubMed ID: 26892006
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the efficacy between paroxetine and sertraline augmented with aripiprazole in patients with refractory major depressive disorder.
Yoshimura R; Kishi T; Hori H; Ikenouchi-Sugita A; Katsuki A; Umene-Nakano W; Iwata N; Nakamura J
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):355-7. PubMed ID: 22813840
[TBL] [Abstract][Full Text] [Related]
30. Paroxetine and the FDA.
Riddle MA
J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):128-30. PubMed ID: 14964296
[No Abstract] [Full Text] [Related]
31. Genome-wide association studies of placebo and duloxetine response in major depressive disorder.
Maciukiewicz M; Marshe VS; Tiwari AK; Fonseka TM; Freeman N; Kennedy JL; Rotzinger S; Foster JA; Kennedy SH; Müller DJ
Pharmacogenomics J; 2018 May; 18(3):406-412. PubMed ID: 28696415
[TBL] [Abstract][Full Text] [Related]
32. Gender differences in the association between antidepressant use and restless legs syndrome.
Baughman KR; Bourguet CC; Ober SK
Mov Disord; 2009 May; 24(7):1054-9. PubMed ID: 19353713
[TBL] [Abstract][Full Text] [Related]
33. Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use.
Wolfersdorf M; Barg T; König F; Leibfarth M; Grünewald I
Pharmacopsychiatry; 1995 Mar; 28(2):56-60. PubMed ID: 7624387
[TBL] [Abstract][Full Text] [Related]
34. Restless Leg Syndrome Induced by Escitalopram and Lithium Combined With Quetiapine Treatment in Bipolar II Disorder: A Case Report.
Chen PH
Clin Neuropharmacol; 2016; 39(2):118-9. PubMed ID: 26818045
[No Abstract] [Full Text] [Related]
35. Antidepressant-Associated Microscopic Colitis: A Case Report and Literature Review.
Salter TG; Williams MD
Psychosomatics; 2017; 58(3):307-312. PubMed ID: 28347506
[No Abstract] [Full Text] [Related]
36. Paroxetine and the FDA.
Connor DF
J Am Acad Child Adolesc Psychiatry; 2004 Feb; 43(2):127. PubMed ID: 14726715
[No Abstract] [Full Text] [Related]
37. Response to duloxetine in a depressed, treatment-resistant adolescent female.
Delgado SV; Saldaña SN; Barzman DH; Coffey B
J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):889-94. PubMed ID: 18315460
[No Abstract] [Full Text] [Related]
38. Collagenous colitis and ileitis under treatment with duloxetine.
Sisman G; Sadri S; Batur S; Dobrucali A
Acta Gastroenterol Belg; 2012 Dec; 75(4):458-9. PubMed ID: 23402093
[No Abstract] [Full Text] [Related]
39. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
[TBL] [Abstract][Full Text] [Related]
40. Antidepressant discontinuation syndrome.
Antai-Otong D
Perspect Psychiatr Care; 2003; 39(3):127-8. PubMed ID: 14606234
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
